Risk factors for infection of implantable cardiac devices: Data from a registry of 2496 patients

Europace

Volumn 15, Issue 1, 2013, Pages 66-70

  Hercé, Benoit ^a   Nazeyrollas, Pierre ^a   Lesaffre, François ^a   Sandras, Raphael ^a   Chabert, Jean Pierre ^a   Martin, Angéline ^a   Tassan Mangina, Sophie ^a   Bui, Huu Tri ^a   Metz, Damien ^a  

^a REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Case control; Implantable cardiac device; Infection; Risk factors

Indexed keywords

AGED; ANTIBIOTIC PROPHYLAXIS; ANTICOAGULANT THERAPY; ARTICLE; ASSISTED CIRCULATION; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART DEVICE; HEART DISEASE; HUMAN; HYPERTENSION; HYPERTHERMIA; IMPLANTATION; INFECTION COMPLICATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; REGISTER;

AGED; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; HYPERTENSION; INCIDENCE; MALE; PACEMAKER, ARTIFICIAL; PROSTHESIS-RELATED INFECTIONS; REGISTRIES; RISK FACTORS;

EID: 84871197049     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus284     Document Type: Article

References (26)

1. Chua J, Wilkoff B, Lee I, Juratli N, Longworth D, Gordon S. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000;133:604-8
2. Cabell C, Heidenreich P, Chu V, Moore C, Stryjewski M, Corey G et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J 2004;147:582-6 (Pubitemid 38900441)
3. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: Results of a large prospective study. Circulation 2007;116:1349-55 (Pubitemid 47417560)
4. Mela T, McGovern B, Garan H, Vlahakes G, Torchiana D, Ruskin J et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter-defibrillator implants. Am J Cardiol 2001;88:750-3
5. Bluhm G. Pacemaker infections. A 2-year follow-up of antibiotic prophylaxis. Scand J Thorac Cardiovasc Surg 1985;19:231-5 (Pubitemid 16231782)
6. Conklin E, Giannelli SJ, Ayres S, Mueller H, Grace W. Prevention of pacemaker infections. N Y State J Med 1973;73:2675-7
7. Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin J et al. Systemic infection related to endocarditis on pacemaker leads: Clinical presentation and management. Circulation 1997;95:2098-107 (Pubitemid 27184278)
8. Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol 2011;58:1001-6
9. Ferguson TJ, Ferguson C, Crites K, Crimmins-Reda P. The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations. J Thorac Cardiovasc Surg 1996;111:742-51; discussion 51-2
10. Spinler SA, Nawarskas JJ, Foote EF, Sabapathi D, Connors JE, Marchlinski FE. Clinical presentation and analysis of risk factors for infectious complications of implantable cardioverter-defibrillator implantations at a university medical center. Clin Infect Dis 1998;26:1111-6 (Pubitemid 28215475)
11. Johansen J, Jorgensen O, Moller M, Arnsbo P, Mortensen P, Nielsen J. Infection after pacemaker implantation: Infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J 2011;32:991-8
12. Sohail M, Uslan D, Khan A, Friedman P, Hayes D, WilsonWet al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 2007;45:166-73 (Pubitemid 47041006)
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70 (Pubitemid 29135798)
14. Aggarwal R, Connelly D, Ray S, Ball J, Charles R. Early complications of permanent pacemaker implantation: No difference between dual and single chamber systems. Br Heart J 1995;73:571-5
15. Catanchin A, Murdock C, Athan E. Pacemaker infections: A 10-year experience. Heart Lung Circ 2007;16:434-9 (Pubitemid 350091403)
16. del Rio A, Anguera I, Miro J, Mont L, Fowler VJ, Azqueta M et al. Surgical treatment of pacemaker and defibrillator lead endocarditis: The impact of electrode lead extraction on outcome. Chest 2003;124:1451-9 (Pubitemid 37290057)
17. Harcombe A, Newell S, Ludman P, Wistow T, Sharples L, Schofield P et al. Late complications following permanent pacemaker implantation or elective unit replacement. Heart 1998;80:240-4 (Pubitemid 28440341)
18. Hill P. Complications of permanent transvenous cardiac pacing: A 14-year review of all transvenous pacemakers inserted at one community hospital. Pacing Clin Electrophysiol 1987;10:564-70 (Pubitemid 17095506)
19. Klug D, Wallet F, Lacroix D, Marquie C, Kouakam C, Kacet S et al. Local symptoms at the site of pacemaker implantation indicate latent systemic infection. Heart 2004;90:882-6 (Pubitemid 39005933)
20. McMahon M, Bistrian B. Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 1995;9:1-9
21. Sohail M, Hussain S, Le K, Dib C, Lohse C, Friedman P et al. Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections. J Interv Card Electrophysiol 2011;31:171-83
22. Da Costa A, Kirkorian G, Cucherat M, Delahaye F, Chevalier P, Cerisier A et al. Antibiotic prophylaxis for permanent pacemaker implantation: A meta-analysis. Circulation 1998;97:1796-801 (Pubitemid 28213623)
23. Bloom H, Heeke B, Leon A, Mera F, Delurgio D, Beshai J et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006;29:142-5
24. Uslan D, Sohail M, St Sauver J, Friedman P, Hayes D, Stoner S et al. Permanent pacemaker and implantable cardioverter defibrillator infection: A populationbased study. Arch Intern Med 2007;167:669-75 (Pubitemid 46598459)
25. Tompkins C, McLean R, Cheng A, Brinker J, Marine J, Nazarian S et al. End-stage renal disease predicts complications in pacemaker and ICD implants. J Cardiovasc Electrophysiol 2011;10:1099-104
26. Kutinsky I, Jarandilla R, Jewett M, Haines D. Risk of hematoma complications after device implant in the clopidogrel era. Circ Arrhythm Electrophysiol 2010;3:312-8